Anti-Human APP Recombinant Antibody(Crenezumab)
-
产品编号
YR1256
-
别名
科研级 Crenezumab ( 克瑞组单抗 ), Anti-APP Recombinant Antibody, Research Grade Crenezumab
-
规格
- 1mg
- 5mg
Catalog Number | YR1256 |
Alias | 科研级 Crenezumab ( 克瑞组单抗 ), Anti-APP Recombinant Antibody, Research Grade Crenezumab |
Size | 1mg, 5mg |
Molecular Name | Crenezumab |
CAS Number | 1095207-05-8 |
Target | APP[Homo sapiens] |
Antibody Isotype | IgG4 Kappa |
Clonity | Monoclonal |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Formulation | PBS, pH7.5 |
Shipping Condition | Shipped on ice packs. |
Background | Crenezumab is a fully humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid-β peptides. |
Remarks | This product is for research use only. |